The COVID-19 pandemic has had an impact on both patients and health practitioners in terms of the number of medical services, type of services and the way in which services are delivered.
Primarily, this report compares data for the first quarter of 2021–22 (the quarter ending September 2021) with the preceding quarter (the quarter ending June 2021) and with the same quarter from the previous year (the quarter ending September 2020). The report examines the impact of the pandemic and associated measures on the:
- Medicare Benefits Scheme (MBS) by presenting the number of MBS services and Government benefits paid; and
- Pharmaceutical Benefits Scheme (PBS) by presenting the number of prescriptions dispensed and Government benefits paid.
- Cat. no: HPF 66
MBS services and benefits paid increased by 13% and 6% respectively in Sep quarter 2021 compared to Sep quarter 2020
Jun to Sep quarters 2021, GP consults up 9% (suitability for COVID vaccine +194%, microbiology tests on referral +72%)
MBS services via telehealth (phone and video conferencing) increased by 51% from Jun quarter to Sep quarter in 2021
The pandemic had minimal impact on total script volumes, with a 2% growth in the year ending Sep 2021 compared to 2020